Pediatric Vitiligo

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


Vitiligo is a disease of pigment loss. Most investigators currently consider vitiligo to be a disorder that occurs as a result of autoimmune destruction of melanocytes, supported by identification of antimelanocyte antibodies in many patients, and the presence of comorbid autoimmune disease in patients with and family members of individuals with vitiligo. One-half of vitiligo cases are of childhood onset. This article presents a current overview of pediatric vitiligo including comorbidities of general health, psychological factors, therapeutic options, and long-term health considerations.

Original languageEnglish
Pages (from-to)347-366
Number of pages20
JournalPediatric Clinics of North America
Issue number2
StatePublished - Apr 2014


  • Autoimmunity
  • Corticosteroids
  • Depigmentation
  • Tacrolimus
  • Vitamin D
  • Vitiligo


Dive into the research topics of 'Pediatric Vitiligo'. Together they form a unique fingerprint.

Cite this